Moxesh Ketanbhai Zota
#751Managing Director
34
Age
13y
Exp
11y
Tenure
5/10
Risk
🎓 B. Pharmacy · Gujarat Technological University
📜 M.Sc. MBA in International Marketing and Business Management · BPP University United Kingdom
🏛️ None
CompensationTBP
Personality
5
Open
6
Cons
4
Extr
5
Agre
4
Neur
Zota Health Care
Healthcare · Small Cap
High Growth · Founder-Centric
About
Moxesh Ketanbhai Zota is the Managing Director of Zota Health Care, a Small Cap company in the Healthcare sector with a market cap of ₹4K Cr. A Pragmatic leader with 13 years of experience, he is known for authority-driven decision-making and organic builder strategy. Focuses on steady geographical growth in the pharmaceutical distribution sector through consistent inventory and network management.
FAQ
What is Moxesh Ketanbhai Zota's leadership style?
Moxesh Ketanbhai Zota is classified as a Pragmatic leader. He is authority-driven in decision-making, with a empire expander motivation and startup-speed pace of execution.
What is Moxesh Ketanbhai Zota's educational background?
Moxesh Ketanbhai Zota holds a B. Pharmacy from Gujarat Technological University and a M.Sc. MBA in International Marketing and Business Management from BPP University United Kingdom.
Who is the CEO of Zota Health Care?
Moxesh Ketanbhai Zota is the Managing Director of Zota Health Care. He has been with the company for 11 years and in the current role for 10 years.
Leadership DNA
ArchetypePragmatic
MotivationEmpire Expander
CrisisSteady Hand
DecisionAuthority-Driven
GrowthOrganic Builder
PeopleNumbers Driven
InnovationFast-Follower
PaceStartup-Speed
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployerSteady Employer
BrandValue-Champion
FocusMarket Expansion
OrientationDeep Specialist
Leadership Evidence
“Focuses on steady geographical growth in the pharmaceutical distribution sector through consistent inventory and network management.”
⚡ Crisis●●●○○
Zota Health Care has maintained consistent operational focus and steady expansion in the pharmaceutical segment without radical pivots or massive layoffs during market fluctuations.
🎯 Motivation●●●○○
The company has aggressively expanded its distribution network and product portfolio across multiple therapeutic segments to increase market presence.
👥 People●●●○○
The management style reflects a pragmatic, performance-oriented approach consistent with the company's focus on operational efficiency and market-share metrics.
📈 Growth●●●●○
The company has primarily scaled by deepening its existing pharmaceutical manufacturing and marketing infrastructure rather than through large-scale M&A.
💡 Innovation●●●○○
The company focuses on expanding its portfolio of generic pharmaceutical formulations and nutraceuticals in established therapeutic segments rather than pioneering new molecular entities.
🏃 Pace●●●○○
Zota has demonstrated an aggressive expansion strategy by rapidly entering multiple international markets and diversifying into diverse healthcare segments like nutraceuticals and ayurveda.
🌱 Purpose●●●○○
The institutional focus remains heavily centered on commercial growth, distribution network expansion, and market share capture within the competitive Indian pharma landscape.
🏷️ Brand●●●○○
The company positions itself as a provider of affordable, high-quality healthcare solutions, emphasizing accessibility and cost-effectiveness in its product offerings.
🤝 Customer●●●○○
Its primary business model relies on a vast network of distributors, stockists, and medical representatives to place products in retail pharmacies and hospitals rather than direct-to-consumer sales.
💼 Employer●●○○○
As a mid-sized, promoter-influenced entity in the pharma sector, it offers a predictable, process-oriented environment typical of regional pharmaceutical firms.
📋 Mandate
Requires R&D-driven product expansion and niche portfolio scaling to break through in a crowded pharmaceutical market.
🏢 Culture●●●○○
Promoter-led healthcare entity with the founder actively involved in the Managing Director role, driving growth strategy.
Financials
Revenue FY25₹293 Cr
PAT FY25₹-563984000
Rev CAGR 5Y30.7%
OPM-16.4%
NPM-19.3%
ROE-25.2%
ROCE-14.2%
P/E—
Fwd P/E—
P/B10.9
D/E56.9
Promoter0%
Institutional0.1%
Mkt Cap₹4K Cr
Compensation
To Be Published
Data being verified from audited reports
